MedTrace Logo

Evaluation of A Reproductive Health Education Program in Women Living With HIV

NCT07423364 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-02-20

No results posted yet for this study

Summary

This study was conducted to evaluate the effectiveness of a reproductive health education program designed and implemented using Pender's Health Promotion Model for women living with HIV.The study was designed as a prospective controlled experimental study.

The hypotheses tested in the study include the following questions:

* Does a "Reproductive Health Education Program" prepared using the Health Promotion Model for women living with HIV increase the reproductive health knowledge level of HIV-positive women?
* Does a "Reproductive Health Education Program" prepared using the Health Promotion Model for women living with HIV positively influence healthy lifestyle behaviors related to women's health among HIV-positive women?
* Does a "Reproductive Health Education Program" prepared using the Health Promotion Model for women living with HIV positively influence lifestyle behaviors related to general health among HIV-positive women?

Conditions

  • HIV (Human Immunodeficiency Virus)

Interventions

BEHAVIORAL

a reproductive health education program

The Health Promotion Model used in the study. The first module was the "Women's Reproductive Health-Sexual Health Module," and the second module was the "HIV/AIDS Healthy Lifestyle Behaviors Module.

Sponsors & Collaborators

  • Okan University

    lead OTHER

Principal Investigators

  • Kenan Oztop · Okan University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-01
Primary Completion
2021-07-01
Completion
2022-06-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07423364 on ClinicalTrials.gov